I

Immunovant

Develops autoimmune disease therapies via R&D

Executive Assistant

Executive SupportConfirmed live in the last 24 hours
Full-timeNew York, NY, USA

About the Job

Requirements

  • At least 5 years of experience supporting C-level executives.
  • Proficiency in Microsoft Office, including Outlook, Word, Excel, and PowerPoint; Adobe Acrobat; and DocuSign.
  • Strong organizational, project management, and problem-solving skills, including the ability to multitask.
  • Strong time-management skills.
  • Strong verbal and written communication skills.
  • Ability to exercise discretion and maintain confidentiality.
  • Strong interpersonal skills.
  • A bachelor's degree is preferred.
  • The role requires approximately 10% domestic or international travel.

Responsibilities

  • Provide administrative and personal support to the CEO and Chief of Staff, including managing a highly active appointment calendar, completing expense reports, arranging detailed business and personal travel, preparing travel itineraries and agendas, compiling documents for travel-related meetings, scheduling appointments, and handling personal errands and matters as needed.
  • Support Board of Directors and Executive Leadership Team meetings by maintaining agendas, scheduling presenters, and collecting, proofreading, and distributing materials in advance.
  • Schedule internal and external meetings, organize conference calls, prioritize requests, protect executives' schedules from unnecessary or conflicting demands, and recommend alternatives.
  • Serve as an administrative contact between the executives and the Board of Directors, employees, and external parties.
  • Assist with general research and company and department projects, including presentations, project trackers, and virtual and in-person events.
  • Respond promptly to executive and team-lead queries.
  • Identify and implement more efficient ways to provide administrative support.

About the Company

Immunovant

Develops autoimmune disease therapies via R&D

Immunovant develops biopharmaceutical therapies to treat autoimmune diseases. Its products aim to modulate the immune system to reduce incorrectly targeted immune activity, using a pipeline advanced through clinical trials and regulatory review. The company builds its solutions through research, development, and potential collaborations with other pharmaceutical firms, and it generates revenue from therapy sales and partnerships. Immunovant differentiates itself by focusing on therapies that aim to change patient outcomes in practical, meaningful ways and by leveraging leadership with extensive pharma experience to drive its programs forward. The ultimate goal is to enable patients with autoimmune diseases to lead normal, more active lives through safe, effective treatments.

Company size
201-500
Company stage
IPO
Headquarters
New York City, United States
Founded
2018

Recently Posted Jobs

Explore more opportunities at Immunovant

See more jobs